NEW YORK – Singular Genomics Systems said on Monday that it is collaborating with Dovetail Genomics, Lexogen, New England Biolabs, Twist Bioscience, and Watchmaker Genomics to integrate its G4 next-generation sequencing platform with those firms' existing NGS products.
Under the partnership with Dovetail Genomics, researchers using G4 will have access to Dovetail’s proximity ligation kit portfolio, designed to capture 3D genome architecture alongside primary sequence information using NGS.
Singular’s collaborations with Lexogen, New England Biolabs, and Watchmaker Genomics will bring G4 users access to these companies’ library preparation technologies. They include Lexogen's RNA library preparation kits QuantSeq, Corall, and Luthor; NEB's NEBNext kits for both DNA and RNA; and Watchmaker’s DNA Library Prep Kits with Fragmentation.
The partnership between Singular and Twist Bioscience will allow G4 users to use Twist’s NGS Target Enrichment Solutions for targeted sequencing.
Financial and other terms of the five deals were not disclosed.
Based in San Diego, Singular Genomics released its G4 sequencer in December 2021 with aims to ship it in the second quarter of this year. The company became public in May 2021. The new partnerships announced today follow a collaboration with the Broad Institute that Singular announced last week.
Jorge Velarde, Singular’s senior VP of corporate development and strategy, said in a statement that each collaboration “underscores our commitment to providing a plug-and-play solution for our customers to seamlessly integrate the G4 into existing NGS workflows."